Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ACP3 | P15309 | 1/20 | 0.46 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | PPARA | Q07869 | 3/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CDC25B | P30305 | 1/20 | 0.40 |
| ▸ | PLK1 | P53350 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146376 | 1.00 | KDM4E (0.50) | KDM4EALDH1A1HSD17B10ACP3NR4A1 | |
| SCHEMBL198219 | 1.00 | KDM4E (0.50) | KDM4EALDH1A1HSD17B10ACP3NR4A1 | |
| SCHEMBL29608063 | 1.00 | KDM4E (0.50) | KDM4EALDH1A1HSD17B10ACP3NR4A1 | |
| SCHEMBL4963997 | 0.90 | ALDH1A1 (0.45) | KDM4EALDH1A1HSD17B10ACP3NR4A1 | |
| SCHEMBL7287554 | 0.85 | KDM4E (0.53) | KDM4EALDH1A1HSD17B10ACP3NR4A1 | |
| SCHEMBL27165013 | 0.85 | KDM4E (0.39) | KDM4EALDH1A1HSD17B10ACP3KIF11 | |
| SCHEMBL28252994 | 0.83 | KIF11 (0.49) | KDM4EALDH1A1KIF11TDP1MEN1 | |
| Norleucine SCHEMBL28063292 | 0.82 | KIF11 (0.51) | KDM4EALDH1A1HSD17B10KIF11TDP1 | |
| SCHEMBL27575255 | 0.82 | KIF11 (0.40) | KDM4EALDH1A1HSD17B10ACP3KIF11 | |
| SCHEMBL4678773 | 0.81 | KDM4E (0.53) | KDM4EALDH1A1HSD17B10ACP3NR4A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1020 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12459973-B2 | Peptide compounds for reducing side effects of CB1 receptor agonists | UNIVERSITAT DE BARCELONA (ES) | 2025-11-04 | — | — | US | claimed |
| WO-2024197259-A1 | TRANSCYTOTIC INTERCELLULAR GELATION ENABLES CELL SPHEROIDS | BRANDEIS UNIVERSITY (US) | 2024-09-26 | — | — | WO | claimed |
| EP-4041748-B1 | PEPTIDE COMPOUNDS FOR REDUCING SIDE EFFECTS OF CB1 RECEPTOR AGONISTS | UNIV BARCELONA (ES) | 2024-05-01 | — | — | EP | claimed |
| US-20240059737-A1 | PEPTIDE COMPOUNDS FOR REDUCING SIDE EFFECTS OF CB1 RECEPTOR AGONISTS | UNIVERSITAT POMPEU FABRA (ES) | 2024-02-22 | — | — | US | claimed |
| US-20230382949-A1 | LINEAR APELIN RECEPTOR AGONISTS | HEPTARES THERAPEUTICS LIMITED (GB) | 2023-11-30 | — | — | US | claimed |
| CN-116710469-A | Linear Apelin receptor agonists | 赫帕雷斯治疗有限公司 | 2023-09-05 | — | — | CN | claimed |
| EP-4225773-A1 | LINEAR APELIN RECEPTOR AGONISTS | Heptares Therapeutics Limited (GB) | 2023-08-16 | — | — | EP | claimed |
| CN-116023438-A | CXCR4 targeting polypeptide and application thereof | 中国药科大学 | 2023-04-28 | — | — | CN | claimed |
| WO-2022079428-A1 | LINEAR APELIN RECEPTOR AGONISTS | HEPTARES THERAPEUTICS LIMITED (GB) | 2022-04-21 | — | — | WO | claimed |
| EP-2922565-B1 | SKIN CARE COMPOSITIONS AND METHODS COMPRISING SELECTIVE AGONISTS OF MELANOCORTIN 1 RECEPTOR | UNIV CINCINNATI (US) | 2019-11-13 | — | — | EP | claimed |
| EP-0647449-A1 | Sustained-release preparation of anti-endothelin substance | Takeda Chemical Industries, Ltd. (JP) | 1995-04-12 | — | — | EP | claimed |
| EP-0540676-B1 | PEPTIDE COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY | POLYGEN HOLDING CORP (US) | 1994-11-17 | — | — | EP | claimed |
| EP-0398961-B1 | POLYPEPTIDE COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY | POLYGEN HOLDING CORP (US) | 1994-11-02 | — | — | EP | claimed |
| EP-0417165-B1 | POLYPEPTIDE COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY | POLYGEN HOLDING CORP (US) | 1994-01-26 | — | — | EP | claimed |
| EP-0552417-A1 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-28 | — | — | EP | claimed |
| EP-0528312-A2 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-02-24 | — | — | EP | claimed |
| EP-0417165-A1 | POLYPEPTIDE COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY. | EASTMAN KODAK CO (US) | 1991-03-20 | — | — | EP | claimed |
| EP-0400051-A1 | POLYPEPTIDE COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY. | EASTMAN KODAK CO (US) | 1990-12-05 | — | — | EP | claimed |
| WO-1989010933-A1 | POLYPEPTIDE COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY | EASTMAN KODAK COMPANY (US) | 1989-11-16 | — | — | WO | claimed |
| WO-1989007110-A1 | POLYPEPTIDE COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY | EASTMAN KODAK COMPANY (US) | 1989-08-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12459973-B2 | Peptide compounds for reducing side effects of CB1 receptor agonists | CNR2, CNR1, OPRD1 | KDM4E 3865/4885ALDH1A1 2428/4885HSD17B10 3740/4885 |
| US-20240059737-A1 | PEPTIDE COMPOUNDS FOR REDUCING SIDE EFFECTS OF CB1 RECEPTOR AGONISTS | CNR2, CNR1, OPRD1 | KDM4E 3719/4885ALDH1A1 2494/4885HSD17B10 3846/4885 |
| US-20230382949-A1 | LINEAR APELIN RECEPTOR AGONISTS | APLNR, MTNR1A, EDNRA | KDM4E 3435/4885ALDH1A1 2876/4885HSD17B10 2197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.